Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5326
PUT
Western Alliance Bancorporation
WAL
$8.91B
| $2.12M | ﹤0.01% |
30,000
-14,600
| -33% | -$1.12M |
|
|
CLAS
5327
DELISTED
Class Acceleration Corp.
CLAS
| $2.12M | ﹤0.01% |
215,725
-600,672
| -74% | -$5.89M |
|
5328
CALL
Eastern Bankshares
EBC
$5.42B
| $2.12M | ﹤0.01% |
114,700
-59,100
| -34% | -$1.15M |
|
|
SAFE
5329
CALL
Safehold
SAFE
$1.07B
| $2.12M | ﹤0.01% |
31,720
+10,929
| +53% | +$920K |
|
5330
CALL
Thryv Holdings
THRY
$90.7M
| $2.12M | ﹤0.01% |
94,500
-58,400
| -38% | -$1.5M |
|
5331
CarGurus
CARG
$3.25B
| $2.12M | ﹤0.01% |
98,400
-154,476
| -61% | -$4.57M |
|
5332
CALL
Establishment Labs
ESTA
$2.28B
| $2.12M | ﹤0.01% |
38,900
-10,100
| -21% | -$641K |
|
5333
PUT
Enovix
ENVX
$788M
| $2.11M | ﹤0.01% |
271,200
+62,400
| +30% | +$587K |
|
5334
Target
TGT
$69.9B
| $2.11M | ﹤0.01% |
14,963
-1,188,637
| -99% | -$228M |
|
|
POSH
5335
CALL
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
| $2.11M | ﹤0.01% |
209,000
-1,100
| -0.5% | -$12.7K |
|
5336
CALL
AdaptHealth
AHCO
$767M
| $2.11M | ﹤0.01% |
117,100
+99,600
| +569% | +$1.62M |
|
5337
ETRACS Alerian MLP Index ETN Series B due July 18 2042
AMUB
$61.4M
| $2.11M | ﹤0.01% |
177,370
+111,359
| +169% | +$1.48M |
|
|
EFOR
5338
Everforth Inc
EFOR
$1.29B
| $2.11M | ﹤0.01% |
+23,388
| New | +$2.4M |
|
|
SLCA
5339
CALL
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $2.11M | ﹤0.01% |
184,800
-61,200
| -25% | -$1.03M |
|
|
DCPH
5340
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $2.11M | ﹤0.01% |
160,400
+6,000
| +4% | +$66.2K |
|
5341
PUT
Atkore
ATKR
$3.17B
| $2.11M | ﹤0.01% |
25,400
-12,300
| -33% | -$1.22M |
|
5342
Franklin FTSE Asia ex Japan ETF
FLAX
$59.2M
| $2.11M | ﹤0.01% |
95,767
-18,742
| -16% | -$422K |
|
|
GOL
5343
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
| $2.11M | ﹤0.01% |
617,832
-126,833
| -17% | -$718K |
|
5344
CALL
ProShares Short S&P500
SH
$851M
| $2.1M | ﹤0.01% |
31,900
+11,250
| +54% | +$695K |
|
5345
CALL
Urban Outfitters
URBN
$6.6B
| $2.1M | ﹤0.01% |
112,700
+20,700
| +23% | +$469K |
|
|
IGAC
5346
PUT
DELISTED
IG Acquisition Corp. Class A Common Stock
IGAC
| $2.1M | ﹤0.01% |
212,400
+59,100
| +39% | +$584K |
|
|
MAXN
5347
CALL
DELISTED
Maxeon Solar Technologies
MAXN
| $2.1M | ﹤0.01% |
1,581
+228
| +17% | +$282K |
|
5348
La-Z-Boy
LZB
$1.65B
| $2.1M | ﹤0.01% |
+88,556
| New | +$2.28M |
|
5349
CALL
CDW
CDW
$17.2B
| $2.1M | ﹤0.01% |
13,300
-6,500
| -33% | -$1.09M |
|
5350
PUT
Medpace
MEDP
$16.3B
| $2.1M | ﹤0.01% |
14,000
+5,900
| +73% | +$854K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.